We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 314

Reply affidavits allowed when new documents introduced in responding evidence

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 9 2014

In this case, there is a partial reversal of evidence. Apotex brought a motion for leave to file reply evidence. Allergan did not oppose parts of the

Court of Appeal strikes paragraphs relating to issue estoppel and abuse of process from statement of defence

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 21 2011

The Court of Appeal heard an appeal from the Motions Judge where the majority of impugned paragraphs in the Statement of Defence were allowed to stand

Documents included in joint book for trial should be exhibits for appeal

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 11 2012

The issue to be determined relates to the contents of the appeal books

Doctrine of bona fide purchaser for value without notice applies to patent rights

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 6 2012

This case involves a dispute over who owned certain patent rights

Declarations of entitlement

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • September 22 2010

Amendments to the Canadian Patent Rules will be coming into effect on October 1, 2010

Merck-Frosst Schering Pharma GP v. Teva Canada

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • September 29 2010

The Federal Court granted a prohibition order, holding that Teva's allegation that the patent at issue was obvious was not justified

PMPRB not found to have jurisdiction over two generic companies in separate decisions

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 2 2014

In the first of two similar decisions, the Federal Court has found that Sandoz Canada is not under the jurisdiction of the PMPRB because Sandoz does

Patent Appeal Board has jurisdiction to consider new defects introduced by the applicants amendments made in response to a final action

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 26 2012

The application relates to a dual balloon catheter

Prohibition order upheld on appeal allegation as to inutility not justified

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • April 23 2012

The Court of Appeal (FCA) upheld the Prohibition Order granted by the Federal Court

Summary judgment re Competition Act claim upheld

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 27 2012

In this patent infringement action, the Federal Court of Appeal (FCA) upheld a decision of the Motions Judge granting summary judgment and dismissing the part of the Plantiff's claims alleging a breach of the Competition Act